Kewaunee Scientific (NASDAQ:KEQU) Shares Cross Above 200-Day Moving Average - Should You Sell?

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report)'s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $46.53 and traded as high as $65.00. Kewaunee Scientific shares last traded at $64.30, with a volume of 17,500 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Wednesday, December 18th.

Kewaunee Scientific Price Performance

The stock's 50 day simple moving average is $55.42 and its 200-day simple moving average is $46.63. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. The firm has a market cap of $184.43 million, a price-to-earnings ratio of 10.18 and a beta of 0.71.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its earnings results on Wednesday, December 11th. The technology company reported $1.41 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Insider Activity at Kewaunee Scientific

In related news, VP Elizabeth D. Phillips sold 1,850 shares of the business's stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the transaction, the vice president now directly owns 13,591 shares in the company, valued at $736,224.47. The trade was a 11.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Douglas J. Batdorff sold 3,470 shares of the stock in a transaction dated Monday, December 30th. The stock was sold at an average price of $65.50, for a total value of $227,285.00. Following the sale, the vice president now directly owns 5,000 shares in the company, valued at $327,500. This represents a 40.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,994 shares of company stock worth $729,430 over the last quarter. Insiders own 14.20% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. De Lisle Partners LLP grew its stake in shares of Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company's stock worth $1,446,000 after purchasing an additional 11,511 shares during the period. State Street Corp purchased a new stake in Kewaunee Scientific during the third quarter worth $266,000. Dimensional Fund Advisors LP grew its position in Kewaunee Scientific by 3.6% during the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company's stock valued at $8,378,000 after buying an additional 6,132 shares during the period. Janney Montgomery Scott LLC purchased a new position in Kewaunee Scientific in the fourth quarter valued at $338,000. Finally, Minerva Advisors LLC raised its position in shares of Kewaunee Scientific by 4.1% in the fourth quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company's stock worth $6,668,000 after acquiring an additional 4,311 shares during the period. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.